Home › Funds › ABRAMS CAPITAL MANAGEMENT, L.P. › NUVB
ABRAMS CAPITAL MANAGEMENT, L.P. position in NUVB
NUVATION BIO INC · Health Care
ABRAMS CAPITAL MANAGEMENT, L.P. reported holding 1,270,504 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$7.1M, representing 0.15% of its reported portfolio and ranking #11 among its reported holdings. ABRAMS CAPITAL MANAGEMENT, L.P. has disclosed NUVB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How ABRAMS CAPITAL MANAGEMENT, L.P.'s NUVB position evolved
ABRAMS CAPITAL MANAGEMENT, L.P. first disclosed a stake in NUVB in Q3 2023 at 3,811,513 shares (US$5.1M). The position peaked in Q4 2025 at 3,811,513 shares, worth US$34.2M. Across 13 filings, ABRAMS CAPITAL MANAGEMENT, L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 1,270,504 shares valued at US$7.1M. Notable position changes include a 67% trim in Q1 2026 (shares rose 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.81M | $5.11M | New |
| Q4 2023 | 3.81M | $5.76M | Hold |
| Q1 2024 | 3.81M | $13.87M | Hold |
| Q2 2024 | 3.81M | $11.13M | Hold |
| Q3 2024 | 3.81M | $8.73M | Hold |
| Q4 2024 | 3.81M | $10.14M | Hold |
| Q1 2025 | 3.81M | $6.71M | Hold |
| Q2 2025 | 3.81M | $7.43M | Hold |
| Q3 2025 | 3.81M | $14.10M | Hold |
| Q4 2025 | 3.81M | $34.15M | Hold |
| Q1 2026 | 1.27M | $5.45M | Reduce |
| Q2 2026 | 1.27M | $7.22M | Hold |
| Q3 2026 | 1.27M | $7.11M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Omega Fund Management, LLC (US$45.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $145.34M · Q3 2026
- Context Capital Management, LLC 52.00M sh · $53.13M · Q3 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.70M sh · $43.10M · Q3 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- Jones Hill Capital LP 4.49M sh · $25.13M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- Nan Fung Group Holdings Ltd 1.33M sh · $7.43M · Q3 2026
More on ABRAMS CAPITAL MANAGEMENT, L.P.
FAQ
How long has ABRAMS CAPITAL MANAGEMENT, L.P. held NUVB?
ABRAMS CAPITAL MANAGEMENT, L.P. has disclosed NUVB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ABRAMS CAPITAL MANAGEMENT, L.P.'s current position in NUVB?
As of Q3 2026, ABRAMS CAPITAL MANAGEMENT, L.P. holds 1.27M shares of NUVB (NUVATION BIO INC), valued at $7.11M, representing 0.15% of its reported portfolio and ranking #11.
Has ABRAMS CAPITAL MANAGEMENT, L.P. been buying or selling NUVB?
In the latest 13F filing (Q3 2026), ABRAMS CAPITAL MANAGEMENT, L.P. held unchanged its position in NUVB. The position peaked in Q4 2025 at 3.81M shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Omega Fund Management, LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.